LDDD on OTC
Longduoduo Co Ltd
Longduoduo Co Ltd is an American health services company, incorporated in Nevada, listed on OTC (LDDD).1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Agape ATP Corp, EUDA Health Holdings Ltd or VSEE HEALTH, INC., or pick any stock.
- TickerLDDD on OTC1
- IndustryServices-Health Services1
- HeadquartersNV1
- Incorporated inNV3
- Business addressG3-5-8016, Shui'An Town, Ruyi Headquarte, Hohhot Economic Development Zone, Hohhot, 0100003
- Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
See how the biggest companies compare on our leaderboards
Longduoduo Company Limited (“Longduoduo”) was incorporated in the State of Nevada on October 25, 2021. Longduoduo’s principal corporate address is G3-5-8016, Shui’an Town, Ruyi Headquarters Base, Hohhot Economic Development District, Hohhot, Inner Mongolia, China, 010000. Our telephone number is +86 (0472) 510 4980. Our registered agent for service of process is Incorp Services, Inc., 3773 Howard Hughes Pkwy, Suite 500S, Las Vegas Nevada 89169-6014. Our website address is www.longduoduo.net. Our website and the information contained on, or that can be accessed through, the website is not deemed to be incorporated by reference in, and is not considered part of, this report, and the inclusion of our website address in this report is an inactive textual reference only. You should not rely on any such information in making your decision whether to purchase our common stock.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Commission Revenue brought in 100% of the revenue Longduoduo Co Ltd broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2025 | 2026 |
|---|---|---|
| Commission Revenue | $4.1M | $1.8M |
| Service Revenue | $120.9K | $6.5K |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue1¢$17.0K
- Selling, general and admin97¢$2.4M
- Income tax3¢$66.5K
Out of $1.8M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Total revenues, net | $1.8M | $4.3M |
| Total cost of revenues | $17.0K | $91.1K |
| Gross profit | $1.8M | $4.2M |
| Selling, general and administrative expenses | $2.4M | $3.6M |
| (Loss) income from operations | -$633.2K | $552.7K |
| Other income, net | $57.4K | $161.8K |
| (Loss) income before provision for income taxes | -$575.8K | $714.5K |
| Provision for income taxes | $66.5K | $222.3K |
| Net (loss) income | -$642.3K | $492.3K |
| Less: net (loss) income attributable to non-controlling interests | -$63.6K | $31.8K |
| Net (loss) income attributable to common stockholders | -$578.6K | $460.4K |
| Foreign currency translation adjustment | $102.0K | $22.9K |
| Comprehensive (loss) income | -$540.3K | $515.2K |
| Less: comprehensive (loss) income attributable to non-controlling interests | -$59.4K | $33.1K |
| Comprehensive (loss) income attributable to the common stockholders | -$480.9K | $482.1K |
| Basic (loss) income per share (in Dollars per share) | -$0.02 | $0.01 |
| Diluted (loss) income per share (in Dollars per share) | -$0.02 | $0.01 |
| Weighted average number of shares outstanding - basic (in Shares) | 30.0M shares | 30.0M shares |
| Weighted average number of shares outstanding - diluted (in Shares) | 30.0M shares | 30.0M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $1.6M | $1.6M | $1.4M |
| Other receivables | $56.9K | $37.3K | |
| Prepayments | $138.3K | $133.6K | |
| Total current assets | $1.8M | $1.8M | |
| Property and equipment, net | $213.0K | $280.0K | |
| Right-of-use assets | $66.3K | $32.9K | |
| Total assets | $2.1M | $2.1M | |
| Accounts payable | $403.5K | $399.9K | |
| Deferred revenue | $790.4K | $335.5K | |
| Accrued expenses | $52.0K | $50.0K | |
| Due to related parties | $3.7K | $408 | |
| Operating lease liabilities, current | $24.1K | $18.6K | |
| Other current liabilities | $9.0K | $26.1K | |
| Total current liabilities | $1.3M | $830.5K | |
| Operating lease liabilities, less current portion | $25.0K | ||
| Total liabilities | $1.3M | $830.5K | |
| Common stock; $0.001 par value, 500,000,000 shares authorized; 30,015,036 and 30,015,036 shares issued and outstanding at June 30, 2026 and 2025 | $30.0K | $30.0K | |
| Additional paid-in capital | $7.2M | $7.2M | |
| Accumulated deficit | -$6.7M | -$6.2M | |
| Accumulated other comprehensive income | $174.8K | $77.0K | |
| Total stockholders equity attributable to the common stockholders | $703.7K | $1.2M | |
| Non-controlling interests | $52.1K | $111.5K | |
| Total stockholders equity | $755.8K | $1.3M | $780.9K |
| Total liabilities and equity | $2.1M | $2.1M | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in Shares) | 30.0M shares | 30.0M shares | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 500.0M shares | 500.0M shares | |
| Common stock, shares issued (in Shares) | 30.0M shares | 30.0M shares | |
| Common stock, shares outstanding (in Shares) | 30.0M shares | 30.0M shares |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $1.6M | $1.6M | $1.4M |
| Other receivables | $56.9K | $37.3K | |
| Prepayments | $138.3K | $133.6K | |
| Total current assets | $1.8M | $1.8M | |
| Property and equipment, net | $213.0K | $280.0K | |
| Right-of-use assets | $66.3K | $32.9K | |
| Total assets | $2.1M | $2.1M | |
| Accounts payable | $403.5K | $399.9K | |
| Deferred revenue | $790.4K | $335.5K | |
| Accrued expenses | $52.0K | $50.0K | |
| Due to related parties | $3.7K | $408 | |
| Operating lease liabilities, current | $24.1K | $18.6K | |
| Other current liabilities | $9.0K | $26.1K | |
| Total current liabilities | $1.3M | $830.5K | |
| Operating lease liabilities, less current portion | $25.0K | ||
| Total liabilities | $1.3M | $830.5K | |
| Common stock; $0.001 par value, 500,000,000 shares authorized; 30,015,036 and 30,015,036 shares issued and outstanding at June 30, 2026 and 2025 | $30.0K | $30.0K | |
| Additional paid-in capital | $7.2M | $7.2M | |
| Accumulated deficit | -$6.7M | -$6.2M | |
| Accumulated other comprehensive income | $174.8K | $77.0K | |
| Total stockholders equity attributable to the common stockholders | $703.7K | $1.2M | |
| Non-controlling interests | $52.1K | $111.5K | |
| Total stockholders equity | $755.8K | $1.3M | $780.9K |
| Total liabilities and equity | $2.1M | $2.1M | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in Shares) | 30.0M shares | 30.0M shares | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 500.0M shares | 500.0M shares | |
| Common stock, shares issued (in Shares) | 30.0M shares | 30.0M shares | |
| Common stock, shares outstanding (in Shares) | 30.0M shares | 30.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -$642.3K | $492.3K |
| Depreciation & amortization | $110.7K | $137.3K |
| Operating lease expense | $41.9K | $63.3K |
| Other receivables | -$17.1K | $95.3K |
| Prepayments | -$2.7K | -$53.1K |
| Due from related parties | $20.1K | |
| Accounts payable | -$18.0K | $36.0K |
| Deferred revenue | $423.7K | -$385.3K |
| Accrued expenses | -$729 | -$776 |
| Due to related parties | $3.3K | -$11.5K |
| Operating lease | -$43.9K | -$19.0K |
| Other payables | -$35.9K | |
| Other current liabilities | -$18.0K | -$61.4K |
| Net cash (used in) provided by operating activities | -$163.1K | $277.4K |
| Purchase of property, plant and equipment | -$30.6K | -$59.4K |
| Net cash used in investing activities | -$30.6K | -$59.4K |
| Effect of exchange rate fluctuation on cash and cash equivalents | $140.0K | $20.7K |
| Net (decrease) increase in cash and cash equivalents | -$53.8K | $238.7K |
| Cash paid for income taxes | $83.0K | $231.6K |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $70.5K |
No quarter-by-quarter statement was filed.
Corporate structure
Longduoduo Co Ltd sits at the top of its group. 10 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Longduoduo Co Ltd
- Liang Zhang Filed SC 13D on Longduoduo Co Ltd, latest Dec 12, 2023
- Longduoduo Co Ltd NV
- Beijing Julong Health Consulting Co. Limited Subsidiary · China
- Beijing Yihua Health Consulting Co., Limited Subsidiary · China
- Inner Mongolia Chengheng Health Consulting Company Limited Subsidiary · China
- Inner Mongolia Qingguo Health Consulting Company Limited Subsidiary · China
- Inner Mongolia Rongbin Health Consulting Company Limited Subsidiary · China
- Inner Mongolia Tianju Health Consulting Company Limited Subsidiary · China
- LDD Technology Limited Subsidiary · British Virgin Islands
- LDDJK Hong Kong Limited Subsidiary · Hong Kong
- Longduoduo Health Technology Company Limited Subsidiary · China
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Longduoduo Co Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $532.7K2 Jun 30, 2026 | $522.6K2 Jun 30, 2025 | +1.9% |
| Accumulated depreciation | $319.6K2 Jun 30, 2026 | $242.6K2 Jun 30, 2025 | +31.8% |
| Property and equipment, net | $213.0K2 Jun 30, 2026 | $280.0K2 Jun 30, 2025 | −23.9% |
| Operating-lease assets (leased space) | $66.3K2 Jun 30, 2026 | $32.9K2 Jun 30, 2025 | +101.4% |
Properties, in its own words
The Company does not own any real property. We believe the premises we now have under lease will be adequate for our operations for the foreseeable future.
Office Leases
The rest of Item 2
On April 1 of 2024, Tianju leased office space (approximately 595 square meters) under an operating lease agreement with Han Ruijun. Under the terms of the agreement, Tianju is committed to make lease payments of approximately $19,000 (RMB137,000) annually for the period between April 1, 2024 and March 31, 2027.
On August 14, 2024, Qingguo leased office space (approximately 482 square meters) under an operating lease agreement with Inner Mongolia Chuangfuhui Enterprise Management Co., Ltd. Under the terms of the agreement, Qingguo was committed to make lease payments of approximately $30,700 (RMB 220,000) for the period between September 10, 2024 and September 10, 2025. Inner Mongolia Chuangfuhui Enterprise Management Co., Ltd, acting as the tenant of the property owner Chen Mingyue, sublet the property to Qingguo. Subsequently, on September 19, 2025, Qingguo entered into a non-cancellable operating lease agreement directly with Chen Mingyue for the same office space. Under terms of the lease agreement, from September 10, 2025, Qingguo is committed to make lease payments totalling approximately $30,898 (RMB 220,000) per year for 1 year. On September 18, 2026, the Company renewed the lease agreement with Chen Mingyue. Under the renewed terms, the Company is obligated to make annual lease payments totaling approximately $32,400 (RMB 220,000) for a one-year term commencing on September 10, 2026.
On November 20, 2024, Chengheng leased an office space (approximately 611 square meters) under an operating lease agreement from Dongsheng District Baiyan Health Consultation Department. Under the terms of the agreement, Chengheng was committed to make lease payments of approximately $16,700 (RMB120,000) for the period between November 20, 2024 and November 20, 2025. The office lease was not renewed upon expiration.
On March 11 of 2025, Longduoduo Health Technology leased office space (approximately 150 square meters) under an operating lease agreement with Liu Libao. Under the terms of the agreement, Longduoduo Health Technology is committed to make lease payments of approximately $4,200 (RMB30,000) for the period between March 11, 2025 and March 10, 2026. On March 11, 2026, Longduoduo Health Technology renewed the lease agreement with Liu Liqiang, who, together with his brother Liu Libao, serves as a co-landlord of the leased premises. Under terms of the lease agreement, from March 11, 2026, Longduoduo Health Technology is committed to make lease payment totalling approximately $3,621 (RMB25,000) per year for 1 year.
On August 8, 2025, Chengheng leased an office space (approximately 400 square meters) under an operating lease agreement from Pan Jirong and Zhong Jing. Under terms of the lease agreement, from August 8, 2025 to August 7, 2028, Chengheng is committed to make lease payments of approximately $24,000 (RMB 170,000) per year for 3 years.
On July 20, 2025, Rongbin leased office space (approximately 97.73 square meters) under an operating lease agreement with Han Yuefei. Under the terms of the agreement, Rongbin is committed to make lease payments of $1,685 (RMB 12,000) per year for the period between July 20, 2025 and July 19, 2026. Rongbin renewed the agreement. Under terms of the lease agreement, from July 20, 2026 to July 19, 2027, Rongbin is committed to make lease payment approximately $1,685 (RMB 12,000) per year
On August 20, 2025, Rongbin leased office space (approximately 626.38 square meters) under an operating lease agreement with Inner Mongolia Baogang Jinmao Real Estate Development Co., Ltd. Under the terms of the agreement, Rongbin is committed to make lease payments of approximately $14,000 (RMB 100,320) per year for the period between September 1, 2025 and August 31, 2026. Rongbin renewed the agreement. Under terms of the lease agreement, from September 1, 2026 to October 6, 2027, Rongbin is committed to make lease payment approximately $14,000 (RMB100,320) per year.
Item 2 of the 10-K filed Sep 30, 2026.5
Leadership
Who has led Longduoduo Co Ltd, and when. Pick a name to see everywhere that person has worked.
- Chief executive officerZhou Hongxiao Dec 11, 2023 to Dec 11, 202312
- Chief financial officerKang Liping Dec 11, 2023 to Dec 11, 202313
Board members and other officers (4)
- Board memberJiayang Ma Jan 31, 2025 to Jan 31, 202514
- Board memberZhijie Li Dec 11, 2023 to Dec 11, 202315
- Board memberZhou Hongxiao Dec 11, 2023 to Dec 11, 202312
- Board memberBo Shan Dec 27, 2023 to Dec 27, 202316
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Beijing Julong Health Consulting Co. Limited China4
- Beijing Yihua Health Consulting Co., Limited China4
- Inner Mongolia Chengheng Health Consulting Company Limited China4
- Inner Mongolia Qingguo Health Consulting Company Limited China4
- Inner Mongolia Rongbin Health Consulting Company Limited China4
- Inner Mongolia Tianju Health Consulting Company Limited China4
- LDD Technology Limited British Virgin Islands4
- LDDJK Hong Kong Limited Hong Kong4
- Longduoduo Health Technology Company Limited China4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Sep 16, 20268-K Executive or director change17
- Apr 11, 20258-K Other events18
- Mar 10, 20258-K Shareholder vote19
- Dec 31, 20248-K Bylaws or fiscal year changed20
- Sep 30, 20248-K Executive or director change21
- Aug 16, 20248-K Change of auditor22
- Mar 27, 20248-K Change of auditor23
- Feb 29, 20248-K Shareholder vote24
- Dec 11, 2023New chief executive Zhou Hongxiao becomes CEO12
- Dec 4, 20238-K Executive or director change25
- Oct 6, 20238-K Change of auditor26
- Sep 27, 20238-K Bylaws or fiscal year changed27
- Aug 22, 20238-K Other events28
Filings
75 filings to the SEC since October 2021: 5 annual reports, 12 quarterly reports, 14 major events, 8 insider forms, 1 large holders, 35 other. The latest 20:
- Sep 30, 202610-K ANNUAL REPORT EDGAR
- Sep 28, 2026NT 10-K NOTIFICATION OF LATE FILING EDGAR
- Sep 16, 20268-K CURRENT REPORT EDGAR
- May 12, 202610-Q QUARTERLY REPORT EDGAR
- Feb 9, 202610-Q QUARTERLY REPORT EDGAR
- Nov 12, 202510-Q QUARTERLY REPORT EDGAR
- Sep 26, 202510-K ANNUAL REPORT EDGAR
- May 14, 202510-Q QUARTERLY REPORT EDGAR
- Apr 11, 20258-K CURRENT REPORT EDGAR
- Mar 10, 20258-K CURRENT REPORT EDGAR
- Feb 14, 202510-Q QUARTERLY REPORT EDGAR
- Feb 3, 2025UPLOAD EDGAR
- Jan 31, 20253 PRIMARY DOCUMENT EDGAR
- Jan 27, 2025CORRESP EDGAR
- Jan 24, 2025UPLOAD EDGAR
- Jan 15, 2025DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
- Dec 31, 20248-K CURRENT REPORT EDGAR
- Nov 14, 202410-Q QUARTERLY REPORT EDGAR
- Oct 15, 2024CORRESP EDGAR
- Oct 15, 202410-K ANNUAL REPORT EDGAR
The 75 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Liang ZhangSC 13D, 1 filing Dec 12, 202329
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2024 | Zhou Hongxiao | $38.2K30 | ||
| 2023 | Zhou Hongxiao | $26.2K30 |
SEC filer profile
How Longduoduo Co Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARLongduoduo Co Ltd1
- CIK0001892316
- Employer ID (EIN)37-20184315
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inNevada5
- Fiscal year endsJune 301
- Industry code (SIC)8000 Services-Health Services1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business addressG3-5-8016, Shui'An Town, Ruyi Headquarte, Hohhot Economic Development Zone, Hohhot, Inner Mongolia 010000, China1
- Phone86 (0472) 510 49801
- Shares outstanding30,015,036 shares as of Sep 30, 20265
- Public float$8.6M as of Dec 31, 20255
- AuditorBush & Associates CPA LLC, Las Vegas, Nevada PCAOB ID 6797; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceNov 10, 20211
- Filings75 in all: 8-K (13), 10-Q (12), CORRESP (9), UPLOAD (9), 3 (8), 10-K (5), NT 10-K (4), S-1/A (4)1
All 16 form types
NT 10-Q (3), DEF 14A (2), 8-A12G (1), 8-K/A (1), DEFA14A (1), EFFECT (1), S-1 (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Sep 30, 2026
Quarterly report (10-Q) May 12, 2026
Proxy statement (DEF 14A) Jan 15, 2025
Latest 8-K (8-K) Sep 16, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| None | NONE |
From the cover page of the 10-K filed Sep 30, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks Longduoduo Co Ltd names in Item 1A of its 10-K filed Sep 30, 2026: 31 risks under these headings, as written.5
- Risks Related to Our Business
- 99.6% of our revenue during the year ended June 30, 2026 came from a single source: Inner Mongolia Honghai Health Management Co., Ltd. Termination of our relationship with Honghai would likely have serious adverse effects on our financial results.
- We rely on third party providers to provide our offered services and could be liable and suffer reputational harm if a third-party service provider provides inferior service or harms a customer, which may have a material adverse effect on our business, financial condition, results of operations and prospects.
- A computer system failure, security breach or a breach of data privacy or security obligations may disrupt our business, damage our reputation and adversely affect our results of operations, financial condition and cash flows.
- We operate in a competitive environment and competing facilities and services could harm our business, financial condition, results of operations and prospects.
- We may not be able to effectively control and manage our planned growth.
- Expansion of our healthcare services could be affected by the expansion of government-sponsored social medical insurance in China if the Company does not qualify for such coverage.
- Additional capital, if needed, may not be available on acceptable terms, if at all, and any additional financing may be on terms adverse to your interests.
- Risks Relating to our Management
- The loss of the services of any of our officers or our failure to timely identify and retain competent personnel could negatively impact our ability to develop our products and sales.
- If we are unable to hire, retain or motivate qualified personnel, consultants, independent contractors, and advisors, we may not be able to grow effectively.
- Our internal controls over financial reporting may not be effective and our independent registered public accounting firm may not be able to certify as to their effectiveness, which could have a significant and adverse effect on our business and reputation.
The other 21 risks
- Limitations on director and officer liability and indemnification of our Company’s officers and directors by us may discourage shareholders from bringing a lawsuit against an officer or director.
- Our management has limited experience managing a public company.
- We may have difficulty establishing adequate management, legal and financial controls in the PRC.
- Risks Related to Doing Business in the PRC
- Changes in United States and China relations, as well as relations with other countries, and/or regulations may adversely impact our business, our operating results, our ability to raise capital and the market price of our shares.
- The operations of our subsidiaries in China, as well as our financial operations in the U.S. to the extent that they affect our subsidiaries in China, will be subject to a high level of control by the national and provincial bureaucracies in the PRC. Exercise by government authorities of that control could significantly interfere with our ability to conduct our operations in the best interests of our company and its shareholders, which could cause the value of our common stock to decline and limit or prevent our efforts to finance the operations of our Chinese subsidiaries.
- The government of China will make a direct intervention into the operations of a China-based company and take control of its operations or significantly restrict its operations if the government believes such action is in the best interests of the Chinese nation.
- Failure to comply with any PRC laws and regulations may adversely affect our business, investments and results of operations.
- Changes in the policies of the PRC government could have an adverse effect on our business.
- Uncertainties with respect to the PRC legal system, including uncertainties regarding the enforcement of laws, and sudden or unexpected changes in laws and regulations in China could adversely affect us and limit the legal protections available to you and us.
- PRC regulation of loans to, and direct investments in, PRC entities by offshore holding companies may delay or prevent us from using our capital reserves to make loans or additional capital contributions to our PRC operating subsidiaries.
- Because our principal assets are located outside of the United States and because all of our directors and all our officers reside in China, it may be difficult for you to use the United States Federal securities laws to enforce your rights against us and our officers or to enforce judgments of United States courts against us or them in the PRC.
- Restrictions contained in Chinese law on the ability of overseas securities regulators to collect information in China may deny investors in our Company the benefits of U.S. securities regulation.
- Governmental control of currency conversion may affect the value of your investment.
- The fluctuation of RMB may materially and adversely affect your investment.
- We may become subject to a variety of laws and regulations in the PRC regarding privacy, data security, cybersecurity, and data protection. We may be liable for improper use or appropriation of personal information provided by our customers.
- We will require the approval of the CSRS before our common stock may become listed on the OTCQB, Nasdaq or any U.S. securities exchange. If we are unable to obtain CSRC’s approval, our ability to raise capital will be limited, which would likely limit the growth of our company.
- If Longduoduo common stock becomes listed on the OTCQB or an exchange, we will be required to obtain the approval of the PRC government for a business combination, the issuance of our common stock, or maintaining our status as a publicly listed company outside China.
- Risks Relating to Our Common Stock
- We are an emerging growth company and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies, our common stock may be less attractive to investors.
- Shareholders do not have pre-emptive rights, which will cause them to experience dilution if we issue additional securities.
- We are unlikely to pay cash dividends in the foreseeable future.
- Our insiders own the majority of the outstanding shares of our stock, and accordingly, will have control over stockholder matters, the Company’s business and management.
Legal proceedings
From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARKang Liping, Chief financial officer
- 14SEC EDGARJiayang Ma, Board member
- 15SEC EDGARZhijie Li, Board member
- 16SEC EDGARBo Shan, Board member
- 17SEC EDGARExecutive or director change
- 18SEC EDGAROther events
- 19SEC EDGARShareholder vote
- 20SEC EDGARBylaws or fiscal year changed
- 21SEC EDGARExecutive or director change
- 22SEC EDGARChange of auditor
- 23SEC EDGARChange of auditor
- 24SEC EDGARShareholder vote
- 25SEC EDGARExecutive or director change
- 26SEC EDGARChange of auditor
- 27SEC EDGARBylaws or fiscal year changed
- 28SEC EDGAROther events
- 29
- 30